BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 10438977)

  • 1. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
    Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
    J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
    Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
    J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytotoxic effector cells: definition and analysis of activity.
    Ortaldo JR
    Allergol Immunopathol (Madr); 1991; 19(4):145-56. PubMed ID: 1726345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
    Kelly-Rogers J; Madrigal-Estebas L; O'Connor T; Doherty DG
    Hum Immunol; 2006 Nov; 67(11):863-73. PubMed ID: 17145366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of human NK cells into NK1 and NK2 subsets.
    Peritt D; Robertson S; Gri G; Showe L; Aste-Amezaga M; Trinchieri G
    J Immunol; 1998 Dec; 161(11):5821-4. PubMed ID: 9834059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B; Gately M; Espevik T
    J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
    Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.
    Fehniger TA; Shah MH; Turner MJ; VanDeusen JB; Whitman SP; Cooper MA; Suzuki K; Wechser M; Goodsaid F; Caligiuri MA
    J Immunol; 1999 Apr; 162(8):4511-20. PubMed ID: 10201989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human CD56bright and CD56dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin.
    Batoni G; Esin S; Favilli F; Pardini M; Bottai D; Maisetta G; Florio W; Campa M
    Scand J Immunol; 2005 Dec; 62(6):498-506. PubMed ID: 16316416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraepithelial lymphocytes in human gut have lytic potential and a cytokine profile that suggest T helper 1 and cytotoxic functions.
    Lundqvist C; Melgar S; Yeung MM; Hammarström S; Hammarström ML
    J Immunol; 1996 Sep; 157(5):1926-34. PubMed ID: 8757311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.
    Lu PH; Negrin RS
    J Immunol; 1994 Aug; 153(4):1687-96. PubMed ID: 7519209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
    Dao T; Mehal WZ; Crispe IN
    J Immunol; 1998 Sep; 161(5):2217-22. PubMed ID: 9725214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2.
    Satoh M; Seki S; Hashimoto W; Ogasawara K; Kobayashi T; Kumagai K; Matsuno S; Takeda K
    J Immunol; 1996 Nov; 157(9):3886-92. PubMed ID: 8892619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
    J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluctuation of peripheral blood T, B, and NK cells during a menstrual cycle of normal healthy women.
    Lee S; Kim J; Jang B; Hur S; Jung U; Kil K; Na B; Lee M; Choi Y; Fukui A; Gilman-Sachs A; Kwak-Kim JY
    J Immunol; 2010 Jul; 185(1):756-62. PubMed ID: 20530263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.